Tender detail

Open-house medicine rebate agreements for indacaterol and mometasone, ATC R03AK14

Summary

The procurement concerns non-exclusive rebate agreements for medicines containing the active ingredients indacaterol and mometasone (ATC R03AK14). Agreements may be concluded at any time during the period from 1 December 2026 to 30 November 2028. Medicines included on the BfArM list of paediatric medicines under Section 35(5a) SGB V are excluded.

Reference number
ebe10d72-342d-4c15-8f88-7dc1ae716579
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-09-30
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.